Group 1 - The company held its 23rd meeting of the 4th Supervisory Board on August 19, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1] - The Supervisory Board approved the proposal for asset impairment provision, stating that it aligns with the company's accounting policies and reflects its financial status accurately [1] - The voting result for the asset impairment provision was unanimous, with 3 votes in favor and no opposition or abstentions [1] Group 2 - The Supervisory Board reviewed and approved the 2025 semi-annual report and its summary, confirming compliance with legal and regulatory requirements [2] - The semi-annual report accurately reflects the company's operational results and financial condition for the first half of 2025, with no false statements or omissions [2] - The voting result for the semi-annual report was also unanimous, with 3 votes in favor and no opposition or abstentions [2]

Group 1 - The board meeting of Zhonglu Co., Ltd. was held on August 15, 2025, with all six directors present, and the meeting was deemed legal and effective [1] - The company approved the use of up to RMB 50 million of idle funds for purchasing high-security and liquid financial products, with the authorization valid for 12 months [2] - The board agreed to recognize an asset impairment provision of RMB 2.3534 million, reflecting the company's financial status and asset value [3] Group 2 - The company revised several internal regulations, including the Independent Director Special Meeting Work Rules and the Related Party Transaction Management System, with unanimous approval from the board [4][5] - Zhonglu Co., Ltd. plans to invest RMB 10 million in Beijing Fulei Technology Co., Ltd., acquiring a 6.25% stake while maintaining the control of the target company [5]

Meeting Details - The 16th meeting of the 8th Supervisory Board of Shenzhen Dashi Intelligent Co., Ltd. was held on August 13, 2025, with all three supervisors participating in the voting [1] - The meeting was chaired by Mr. Li Jizhao, and the company secretary Mr. Lv Feng attended as a guest [1] Meeting Resolutions - The Supervisory Board unanimously agreed (3 votes in favor, 0 against, 0 abstentions) that the procedures for preparing and reviewing the company's 2025 semi-annual report complied with legal and regulatory requirements, and the report accurately reflects the company's actual situation [1] - The Supervisory Board also unanimously approved (3 votes in favor, 0 against, 0 abstentions) the asset impairment provision, confirming that the process was legal and did not harm the interests of the company or its shareholders, especially minority shareholders [2] - The Supervisory Board agreed (3 votes in favor, 0 against, 0 abstentions) to use up to RMB 50 million of idle raised funds for cash management, ensuring it would not affect the company's operations or project implementation [3]

Core Viewpoint - The company, Henan Shijia Photon Technology Co., Ltd., has announced an increase in the expected daily related transaction limit for 2025, amounting to 28 million yuan, which is deemed necessary for its normal business operations and will not adversely affect its financial status or operating results [3][4][18]. Group 1: Company Overview - The company is identified by the stock code 688313 and is referred to as Shijia Photon [1]. - The board of directors guarantees the authenticity, accuracy, and completeness of the semi-annual report [1]. Group 2: Financial Data - The company reported a total asset impairment loss of 16.3583 million yuan for the first half of 2025, which includes credit impairment losses of 4.6612 million yuan and inventory impairment losses of 11.5848 million yuan [21][22][23]. Group 3: Daily Related Transactions - The company has approved an increase in the expected daily related transaction limit for 2025, which is necessary for its business development and complies with fair pricing principles [3][4][18]. - The related transactions are conducted under fair market conditions and do not harm the interests of shareholders, particularly minority shareholders [5][7]. Group 4: Cash Management - The company plans to use up to 400 million yuan of temporarily idle self-owned funds for cash management, aiming to enhance fund utilization efficiency without affecting normal business operations [26][27][30]. - The cash management will involve low-risk financial products, ensuring safety and liquidity [31][33].

Meeting Details - The second meeting of the sixth Supervisory Board of Dirui Medical Technology Co., Ltd. was held on July 21, 2025, combining on-site and communication methods, with all three supervisors present [1][2] - The meeting was legally valid as it complied with the company's articles of association [1] Resolutions Passed - The Supervisory Board unanimously approved the proposal for asset impairment provision, confirming it aligns with accounting standards and reflects the company's financial information accurately [1][2] - The voting result for the asset impairment provision was 3 votes in favor, 0 against, and 0 abstentions, representing 100% of valid voting rights [2] - The Supervisory Board also unanimously approved the proposal to reappoint Da Xin Accounting Firm as the auditing institution for the 2025 fiscal year, affirming its independence and capability [2] - The voting result for the reappointment of the auditing firm was also 3 votes in favor, 0 against, and 0 abstentions, representing 100% of valid voting rights [2] - This proposal will be submitted for approval at the company's shareholders' meeting [2] Reference Documents - The resolutions from the second temporary meeting of the sixth Supervisory Board are available for review [2]

Core Viewpoint - The company reported a decline in revenue and net profit for the year 2024, primarily due to falling prices of pesticide products, despite an increase in production and sales volume [18]. Group 1: Company Overview - The company, Haier Pharmaceutical Group Co., Ltd., is engaged in the research, production, and sales of pesticide formulations, intermediates, and raw materials, with a focus on insecticides and fungicides [4][15]. - The pesticide industry is characterized by relatively inelastic demand, playing a crucial role in agricultural production and food security [2][3]. Group 2: Financial Performance - The company achieved operating revenue of CNY 3.91 billion in 2024, a decrease of 11.16% from CNY 4.40 billion in 2023 [18]. - The net profit attributable to shareholders was CNY 181.37 million, down 61.67% from CNY 473.20 million in the previous year [18]. - The net cash flow from operating activities was CNY 285.55 million, a significant decrease of 70.11% compared to CNY 955.35 million in 2023 [18]. Group 3: Market Dynamics - The global demand for pesticides is expected to grow due to increasing food security needs and agricultural efficiency [2]. - China's pesticide production capacity is shifting towards countries like China and India, driven by the expiration of patents and restructuring by multinational agrochemical giants [2][3]. Group 4: Product Development - The company has been diversifying its pesticide offerings, with several new products entering trial production in recent years, including various insecticides and fungicides [4][5]. - The company is focusing on high-efficiency, low-toxicity pesticides to meet the growing market demand [2][4]. Group 5: Industry Trends - The pesticide industry is experiencing a shift towards biopesticides and environmentally friendly products, with increasing market share for biological and chemical pesticides [7]. - The market for generic pesticides is expected to expand as patents expire, providing opportunities for companies with strong R&D capabilities [2][3].

Group 1 - The company has proposed to reappoint Ernst & Young Hua Ming as its financial audit and internal control audit institution for the year 2025, with a term of one year, pending approval at the shareholders' meeting [2][10][11] - Ernst & Young Hua Ming was established in September 1992 and has a strong focus on talent development, with over 1,700 certified public accountants, including more than 500 with experience in securities-related services [2][3] - The audit firm reported a total revenue of RMB 5.955 billion in 2023, with audit service revenue of RMB 5.585 billion and securities service revenue of RMB 2.438 billion [2] Group 2 - The audit firm has a good investor protection capability, having set aside a professional risk fund and purchased professional liability insurance with a total coverage exceeding RMB 200 million [3] - In the past three years, Ernst & Young Hua Ming has not faced any civil lawsuits related to its professional conduct [3][5] - The firm has maintained a clean record with no criminal or administrative penalties in the last three years [5][7] Group 3 - The project partner and lead auditor, Liu Chong, has been a registered accountant since 2010 and has been providing audit services to the company since 2021 [6] - The second signing auditor, Zhao Pu, has been with the firm since 2021 and has also been involved in auditing the company [6] - The quality review partner, Tan Zhao Hui, has extensive experience in auditing and has been with Ernst & Young Hua Ming since 1993 [6] Group 4 - The audit fee for 2024 is set at RMB 2.5411 million, which includes tax, and the fee structure will remain unchanged for 2025 [9] - The audit committee unanimously approved the reappointment of Ernst & Young Hua Ming, citing their adherence to independent and objective auditing standards [10][11] - The board of directors also supported the reappointment, emphasizing the audit firm's professional competence and ethical conduct [11][12] Group 5 - The shareholders' meeting is scheduled for May 16, 2025, to discuss various proposals, including the reappointment of the audit firm [16][17] - The meeting will utilize a combination of on-site and online voting methods [16] - The company has outlined specific procedures for shareholders to register and participate in the meeting [20][22]

Financial Performance - The company's revenue for the first quarter of 2025 decreased due to a strategic and operational model transformation, with a total of 47 stores modified, leading to a decline in overall revenue as 273 stores were closed compared to the same period last year [1][2] - The net profit attributable to shareholders decreased primarily due to a 1.35 percentage point drop in gross margin, influenced by the optimization of product structure and procurement during the store modifications [1][2] - The fair value change loss of Advantage Solutions stock amounted to -172 million yuan, resulting in a profit decrease of 249 million yuan compared to the same period last year [1] Operational Highlights - As of March 31, 2025, online business revenue reached 3.15 billion yuan, accounting for 18.02% of total revenue [5] - The "Yonghui Life" app covered 670 stores, generating sales of 1.75 billion yuan, with an average daily order volume of 231,000 and a monthly repurchase rate of 47.6% [6] - The company accelerated store modifications, focusing on quality retail, with a total of 61 modified stores by the report date [7] Shareholder Information - The company proposed not to distribute cash dividends or implement other forms of distribution for the 2024 fiscal year, as the net profit attributable to shareholders was negative for four consecutive years [9][14] - The profit distribution plan has been approved by the board and will be submitted for shareholder meeting approval [10][12] Governance and Risk Management - The company plans to purchase liability insurance for directors, supervisors, and senior management to enhance risk management and protect the interests of the company and investors [18] - The board of directors has proposed to appoint Wang Shoucheng as a non-independent director, pending approval at the upcoming shareholder meeting [20] Audit and Compliance - The company intends to renew its contract with Ernst & Young Huaming for the 2025 financial audit, with the proposal having been approved by the board and requiring shareholder meeting approval [49][57]

Meeting Overview - The fifth board meeting of Suzhou Shijia Technology Co., Ltd. was held on April 24, 2025, with all five directors present, complying with relevant regulations [2][4]. Resolutions Passed - The board approved the change in accounting policy, with details available on the official website [5][3]. - The board approved the provision for asset impairment, pending review at the 2024 annual shareholders' meeting [5][7]. - The board approved the profit distribution plan for 2024, also pending review at the annual shareholders' meeting [8][10]. - The board approved the general manager's work report for 2024 [11]. - The board approved the board's work report for 2024, with details available in the annual report [12]. - The board approved the financial settlement report for 2024, showing total assets of 1,461.61 million yuan, a 0.02% decrease year-on-year, and a net profit of 92.12 million yuan, a 727.14% increase year-on-year [14][15]. - The board approved the internal control evaluation report for 2024 [18]. - The board approved the annual report and its summary for 2024 [21]. - The board approved the application for comprehensive credit limits and guarantees from financial institutions [25]. - The board approved the establishment of a bill pool business [28]. - The board approved the provision of financial assistance [30]. - The board approved the foreign exchange hedging business [32]. - The board approved the use of idle funds to purchase financial products [35]. - The board approved the execution of director remuneration for 2024, with specific amounts detailed for each director [37][46]. - The board approved the reappointment of the auditing firm for 2025 [49][51]. - The board approved the proposal regarding unremedied losses reaching one-third of the paid-in capital, outlining measures to address the situation [53][55]. - The board approved the repurchase and cancellation of certain restricted stocks due to the departure of two incentive targets [58]. - The board approved the proposal to authorize the board to handle small-scale rapid financing matters, with a limit of 300 million yuan [59]. - The board approved the first quarter report for 2025 [60]. - The board approved the convening of the 2024 annual shareholders' meeting on May 15, 2025 [62]. Financial Performance - The company reported a total asset of 1,461.61 million yuan, a slight decrease of 0.02% year-on-year [14]. - The net profit attributable to the parent company was 92.12 million yuan, reflecting a significant increase of 727.14% year-on-year [14]. - Earnings per share rose to 0.37 yuan, marking a 716.67% increase year-on-year [14]. Shareholders' Meeting Details - The annual shareholders' meeting is scheduled for May 15, 2025, with provisions for both on-site and online voting [65][66]. - The meeting will address various proposals, including special resolutions requiring a two-thirds majority for approval [73].

Core Viewpoint - The Supervisory Board of Jilin Quanyangquan Co., Ltd. has approved several proposals regarding the 2024 annual report and profit distribution plan, which will be submitted for approval at the 2024 annual shareholders' meeting [1][2][3][4]. Group 1: Profit Distribution Plan - The profit distribution plan for 2024 has been deemed compliant with relevant laws and regulations, and it considers the company's actual situation, benefiting both the company and its shareholders [1][2]. - The proposal received unanimous approval from all five attending supervisors, with no votes against or abstentions [1][2]. Group 2: Annual Report - The Supervisory Board confirmed that the preparation and review process of the 2024 annual report complies with legal and regulatory requirements, accurately reflecting the company's financial status and operational results [2][3]. - The report has been audited by Dahua Certified Public Accountants, which issued an unqualified opinion, affirming the objectivity and accuracy of the financial information presented [2][3]. Group 3: Asset Impairment Provision - The Supervisory Board agreed to the provision for asset impairment, which is expected to provide a more accurate representation of the company's asset status [3]. - This proposal also requires approval at the upcoming shareholders' meeting [3]. Group 4: Fund Utilization Adjustment - The Supervisory Board approved adjustments to the scale of certain fundraising investment projects, reallocating some funds for new projects to enhance operational efficiency and competitiveness [3][4]. - The adjustments are in line with regulatory requirements and do not harm the interests of minority shareholders [3][4].